Insider Selling: National Research Corp. (NRCIB) CEO Sells 1,500 Shares of Stock
National Research Corp. (NASDAQ:NRCIB) CEO Michael D. Hays sold 1,500 shares of the company’s stock in a transaction on Tuesday, September 20th. The shares were sold at an average price of $16.28, for a total transaction of $24,420.00. Following the completion of the sale, the chief executive officer now owns 6,467,744 shares of the company’s stock, valued at approximately $105,294,872.32. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
National Research Corp. (NASDAQ:NRCIB) traded up 1.6323% during mid-day trading on Wednesday, reaching $36.1811. 236 shares of the company traded hands. The stock has a market capitalization of $876.34 million, a PE ratio of 44.4485 and a beta of 0.28. National Research Corp. has a 52-week low of $31.36 and a 52-week high of $44.60. The firm’s 50-day moving average is $33.92 and its 200 day moving average is $35.16.
National Research Corp. (NASDAQ:NRCIB) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $0.18 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.18. National Research Corp. had a net margin of 18.75% and a return on equity of 33.74%. On average, equities research analysts expect that National Research Corp. will post $0.82 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be given a $0.48 dividend. This represents a $1.92 annualized dividend and a yield of 5.31%. The ex-dividend date is Wednesday, September 28th. National Research Corp.’s dividend payout ratio (DPR) is 408.52%.
An institutional investor recently bought a new position in National Research Corp. stock. WCM Investment Management CA purchased a new position in National Research Corp. (NASDAQ:NRCIB) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 46,808 shares of the company’s stock, valued at approximately $1,554,000. WCM Investment Management CA owned approximately 0.19% of National Research Corp. at the end of the most recent reporting period. 2.90% of the stock is currently owned by institutional investors and hedge funds.
Separately, Zacks Investment Research upgraded shares of National Research Corp. from a “hold” rating to a “buy” rating and set a $37.00 price target for the company in a research report on Friday, August 12th.
National Research Corp. Company Profile
National Research Corp. is a business services company in the Health Care Services industry.
Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.